search
Back to results

Effect of Cranberry Capsules on Urinary Infection Rates in Spinal Cord Injured Patients During Post Acute Rehabilitation

Primary Purpose

Spinal Cord Injury, Urinary Tract Infection, Rehabilitation

Status
Terminated
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Cranberry capsules
Sponsored by
Uppsala University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Spinal Cord Injury focused on measuring urinary tract infection, prevention, rehabilitation, spinal cord injury

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Previously essentially healthy
  2. Newly acquired spinal cord injury, T12 level or higher
  3. Receiving in-patient care on the rehabilitation ward.
  4. Expected admission duration >= 4 weeks
  5. 16 years old or older

Exclusion Criteria:

  1. Current or previous disorder that increases the risk of urinary tract infection including diabetes, urological disorder, previous operation on urinary tracts or kidneys, immune dysfunction
  2. Severe head injury with impairment of cognitive function
  3. Allergy to cranberry
  4. Renal failure
  5. Warfarin (Coumarin) treatment with unstable INR
  6. Current symptomatic urinary tract infection

Sites / Locations

  • Dept of Rehabilitation Medicine, University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Cranberry capsule

Placebo capsule

Arm Description

Outcomes

Primary Outcome Measures

Number of symptomatic urinary tract infections per patient per month during in-patient post acute rehabilitation

Secondary Outcome Measures

Percentage of in-patient rehabilitation days on which patients were unable to participate in active rehabilitation due to urinary tract infection.
Patient's experience of urinary symptoms in the absence of symptomatic urinary tract infection.

Full Information

First Posted
February 19, 2010
Last Updated
May 13, 2016
Sponsor
Uppsala University
search

1. Study Identification

Unique Protocol Identification Number
NCT01079169
Brief Title
Effect of Cranberry Capsules on Urinary Infection Rates in Spinal Cord Injured Patients During Post Acute Rehabilitation
Official Title
Evaluation of the Effect of Cranberry Capsules on the Occurrence of Urinary Tract Infections During Post-acute Rehabilitation of Spinal Cord Injured Patients
Study Type
Interventional

2. Study Status

Record Verification Date
May 2016
Overall Recruitment Status
Terminated
Why Stopped
Terminated early due to recruitment difficulties
Study Start Date
March 2010 (undefined)
Primary Completion Date
March 2012 (Actual)
Study Completion Date
March 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Uppsala University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to establish whether cranberry capsules reduce rates of urinary tract infections during initial rehabilitation immediately after spinal cord injury.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injury, Urinary Tract Infection, Rehabilitation
Keywords
urinary tract infection, prevention, rehabilitation, spinal cord injury

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
3 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cranberry capsule
Arm Type
Experimental
Arm Title
Placebo capsule
Arm Type
Placebo Comparator
Intervention Type
Dietary Supplement
Intervention Name(s)
Cranberry capsules
Intervention Description
Cranberry capsules, 550mg, or placebo capsules, two capsules three times daily during in-patient rehabilitation
Primary Outcome Measure Information:
Title
Number of symptomatic urinary tract infections per patient per month during in-patient post acute rehabilitation
Time Frame
At end of study
Secondary Outcome Measure Information:
Title
Percentage of in-patient rehabilitation days on which patients were unable to participate in active rehabilitation due to urinary tract infection.
Time Frame
At end of Study
Title
Patient's experience of urinary symptoms in the absence of symptomatic urinary tract infection.
Time Frame
At end of study

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Previously essentially healthy Newly acquired spinal cord injury, T12 level or higher Receiving in-patient care on the rehabilitation ward. Expected admission duration >= 4 weeks 16 years old or older Exclusion Criteria: Current or previous disorder that increases the risk of urinary tract infection including diabetes, urological disorder, previous operation on urinary tracts or kidneys, immune dysfunction Severe head injury with impairment of cognitive function Allergy to cranberry Renal failure Warfarin (Coumarin) treatment with unstable INR Current symptomatic urinary tract infection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alison K Godbolt, MbChB MD
Organizational Affiliation
University Hospital Uppsala
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dept of Rehabilitation Medicine, University Hospital
City
Uppsala
ZIP/Postal Code
75185
Country
Sweden

12. IPD Sharing Statement

Learn more about this trial

Effect of Cranberry Capsules on Urinary Infection Rates in Spinal Cord Injured Patients During Post Acute Rehabilitation

We'll reach out to this number within 24 hrs